Recently, the use of pro-drug-loaded stimuli-responsive drug delivery systems to facilitate the delivery of anticancer drugs has become a notable trend (Jia et al., 2018 ; Yang et al., 2018 ).
← all excerpts
A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells.
1
—
—